Hhlr Advisors
Hhlr Advisors reported 35 stocks worth $832M in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are LEGN (20.8%), FUTU (19.9%) and AVBP (16.4%). Compared with Q1 2026, the fund opened new positions in ALMR, ODTX and NTES, added to FUTU, VIPS and LITE, trimmed MRVL, PDD and BEKE and sold out of ONC, B and DDL.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 | ![]() LEGN Legend Biotech Corp | $173M | 20.8% | 6M | No change | 8 of 8 | |
| 2 | ![]() FUTU Futu Hldgs Ltd | $166M | 19.9% | 1.8M | +349K (+25%) | 8 of 8 | |
| 3 | ![]() AVBP Arrivent Biopharma Inc | $136M | 16.4% | 3.9M | No change | 8 of 8 | |
| 4 | ![]() MRVL Marvell Technology Inc | $48.5M | 5.8% | 163K | −8,100 (−5%) | 2 of 8 | |
| 5 | ![]() VIPS Vipshop Hldgs Ltd | $46M | 5.5% | 3.5M | +3.3M (+2683%) | 6 of 8 | |
| 6 | ![]() PDD Pdd Holdings Inc | $38.1M | 4.6% | 500K | −3.7M (−88%) | 8 of 8 | |
| 7 | ![]() BEKE KE Hldgs Inc | $32.2M | 3.9% | 2.2M | −2M (−48%) | 8 of 8 | |
| 8 | ![]() CTKB Cytek Biosciences Inc | $29.5M | 3.5% | 6.7M | No change | 8 of 8 | |
| 9 | ![]() ALMR Alamar Biosciences Inc | $25.9M | 3.1% | 956K | New position | 1 of 8 | |
| 10 | ![]() BABA Alibaba Group Hldg Ltd F | $17.7M | 2.1% | 184K | −2.3M (−93%) | 8 of 8 |
Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q1 2026, gone in Q2 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
![]() ONC Beone Medicines Ltd | $307M | 1M |
CLEARWATER ANALYTICS HLDGS I | $32.3M | 1.4M |
![]() B Barrick Mng Corp | $1M | 25K |
![]() DDL Dingdong Cayman Ltd F | $911K | 355K |
![]() AXIAY Centrais Eletricas Brasileir | $712K | 63K |
🔒 Free account: see all 9.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q2 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Aug 14, 2026 | 13F-HR | Q2 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Hhlr Advisors 13F FAQ
What does Hhlr Advisors own?
Hhlr Advisors reported 35 stocks worth $832M in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are LEGN (20.8%), FUTU (19.9%) and AVBP (16.4%). The table above lists every position in the filing (the top 10 without an account).
What did Hhlr Advisors buy and sell in Q2 2026?
Compared with Q1 2026: 6 new positions, 6 added to, 6 trimmed and 9 sold out. New positions include ALMR, ODTX and NTES. It sold all of ONC, B and DDL.
When will Hhlr Advisors file its next 13F?
Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.
How much is Hhlr Advisors's portfolio worth?
The Q2 2026 filing reports $832M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.













